ANIXA BIOSCIENCES, INC. Payments for (Proceeds from) Other Investing Activities
ANIXA BIOSCIENCES, INC. (ANIX) reported Payments for (Proceeds from) Other Investing Activities of $6.68 thousand for the 12-month period ending 2014-10-31, per its 10-K filed 2015-01-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2015-08-18
- ANIXA BIOSCIENCES, INC. payments for (proceeds from) other investing activities for the quarter ending 2014-10-31 was $2.89K.
- ANIXA BIOSCIENCES, INC. payments for (proceeds from) other investing activities for the quarter ending 2014-07-31 was $2.47K, a 125.07% increase year-over-year.
- ANIXA BIOSCIENCES, INC. payments for (proceeds from) other investing activities for the quarter ending 2013-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. payments for (proceeds from) other investing activities for the quarter ending 2013-07-31 was $1.10K.
- ANIXA BIOSCIENCES, INC. payments for (proceeds from) other investing activities for fiscal 2014 was $6.68K, a 888.76% increase from fiscal 2013.
- ANIXA BIOSCIENCES, INC. payments for (proceeds from) other investing activities for fiscal 2013 was $676.00, a 12.67% increase from fiscal 2012.
- ANIXA BIOSCIENCES, INC. payments for (proceeds from) other investing activities for fiscal 2012 was $600.00.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|---|
| 2014-10-31 | $2.89K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $5.36K derived: sum of 2 quarters · filed 2015-08-18 | $6.68K 10-K · filed 2015-01-29 | |
| 2014-07-31 | $2.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $3.80K 10-Q · filed 2015-08-18 | ||
| 2014-04-30 | $1.33K 10-Q · filed 2015-05-22 | |||
| 2013-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $1.10K derived: sum of 2 quarters · filed 2015-01-29 | -$654.00 derived: sum of 3 quarters · filed 2015-01-29 | $676.00 10-K · filed 2015-01-29 |
| 2013-07-31 | $1.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | -$654.00 derived: sum of 2 quarters · filed 2014-09-15 | $676.00 10-Q · filed 2014-09-15 | |
| 2013-04-30 | -$1.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-16 | -$421.00 10-Q · filed 2014-06-16 | ||
| 2013-01-31 | $1.33K 10-Q · filed 2014-03-17 | |||
| 2012-10-31 | $600.00 10-K/A · filed 2014-01-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |